Literature DB >> 26495952

Neuroimaging characteristics of ruptured aneurysm as predictors of outcome after aneurysmal subarachnoid hemorrhage: pooled analyses of the SAHIT cohort.

Blessing N R Jaja1,2,3, Hester Lingsma4, Ewout W Steyerberg4, Tom A Schweizer1,2,3, Kevin E Thorpe2,5, R Loch Macdonald1,2,3.   

Abstract

OBJECT Neuroimaging characteristics of ruptured aneurysms are important to guide treatment selection, and they have been studied for their value as outcome predictors following aneurysmal subarachnoid hemorrhage (SAH). Despite multiple studies, the prognostic value of aneurysm diameter, location, and extravasated SAH clot on computed tomography scan remains debatable. The authors aimed to more precisely ascertain the relation of these factors to outcome. METHODS The data sets of studies included in the Subarachnoid Hemorrhage International Trialists (SAHIT) repository were analyzed including data on ruptured aneurysm location and diameter (7 studies, n = 9125) and on subarachnoid clot graded on the Fisher scale (8 studies; n = 9452) for the relation to outcome on the Glasgow Outcome Scale (GOS) at 3 months. Prognostic strength was quantified by fitting proportional odds logistic regression models. Univariable odds ratios (ORs) were pooled across studies using random effects models. Multivariable analyses were adjusted for fixed effect of study, age, neurological status on admission, other neuroimaging factors, and treatment modality. The neuroimaging predictors were assessed for their added incremental predictive value measured as partial R(2). RESULTS Spline plots indicated outcomes were worse at extremes of aneurysm size, i.e., less than 4 or greater than 9 mm. In between, aneurysm size had no effect on outcome (OR 1.03, 95% CI 0.98-1.09 for 9 mm vs 4 mm, i.e., 75th vs 25th percentile), except in those who were treated conservatively (OR 1.17, 95% CI 1.02-1.35). Compared with anterior cerebral artery aneurysms, posterior circulation aneurysms tended to result in slightly poorer outcome in patients who underwent endovascular coil embolization (OR 1.13, 95% CI 0.82-1.57) or surgical clipping (OR 1.32, 95% CI 1.10-1.57); the relation was statistically significant only in the latter. Fisher CT subarachnoid clot burden was related to outcome in a gradient manner. Each of the studied predictors accounted for less than 1% of the explained variance in outcome. CONCLUSIONS This study, which is based on the largest cohort of patients so far analyzed, has more precisely determined the prognostic value of the studied neuroimaging factors. Treatment choice has strong influence on the prognostic effect of aneurysm size and location. These findings should guide the development of reliable prognostic models and inform the design and analysis of future prospective studies, including clinical trials.

Entities:  

Keywords:  ACA = anterior cerebral artery; CONSCIOUS-1 = Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After SAH; D-SAT = University of Washington Database of Subarachnoid Treatment; GOS = Glasgow Outcome Scale; ICA = internal carotid artery; IQR = interquartile range; ISAT = International Subarachnoid Aneurysm Trial; MCA= middle cerebral artery; OR = odds ratio; RCT = randomized clinical trial; SAH = subarachnoid hemorrhage; SAHIT = Subarachnoid Hemorrhage International Trialists; SHOP = Subarachnoid Hemorrhage Outcomes Project; WFNS = World Federation of Neurosurgical Societies; intracranial aneurysm; meta-analysis; outcome assessment; risk factors; subarachnoid hemorrhage; vascular disorders

Mesh:

Year:  2015        PMID: 26495952     DOI: 10.3171/2015.4.JNS142753

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  5 in total

1.  Prediction of Outcome Using Quantified Blood Volume in Aneurysmal SAH.

Authors:  W E van der Steen; H A Marquering; L A Ramos; R van den Berg; B A Coert; A M M Boers; M D I Vergouwen; G J E Rinkel; B K Velthuis; Y B W E M Roos; C B L M Majoie; W P Vandertop; D Verbaan
Journal:  AJNR Am J Neuroradiol       Date:  2020-05-14       Impact factor: 3.825

2.  Assessing Contribution of Higher Order Clinical Risk Factors to Prediction of Outcome in Aneurysmal Subarachnoid Hemorrhage Patients.

Authors:  Azade Tabaie; Shamim Nemati; Jason W Allen; Charlotte Chung; Flavia Queiroga; Won-Jun Kuk; Adam B Prater
Journal:  AMIA Annu Symp Proc       Date:  2020-03-04

3.  Rs10230207 genotype confers changes in HDAC9 and TWIST1, but not FERD3L in lymphoblasts from patients with intracranial aneurysm.

Authors:  Theresa A Lansdell; Courtney Fisher; Kent Simmonds; Mat J Reeves; Daniel Woo; Anne M Dorrance; Stacie L Demel
Journal:  Neurogenetics       Date:  2019-03-27       Impact factor: 3.017

4.  Association between physical restraint requirement and unfavorable neurologic outcomes in subarachnoid hemorrhage.

Authors:  Kyoko Akiyama; Akihiko Inoue; Toru Hifumi; Kentaro Nakamura; Takuya Taira; Shun Nakagawa; Keisuke Jinno; Arisa Manabe; Sayaka Kinugasa; Hikaru Matsumura; Hajime Shishido; Shota Yokoyama; Tomoya Okazaki; Hideyuki Hamaya; Koshiro Takano; Kazutaka Kiridume; Natsuyo Shinohara; Kenya Kawakita; Yasuhiro Kuroda
Journal:  J Intensive Care       Date:  2021-03-12

5.  Factors Influencing 1-year Functional Outcome after Surgery in Aneurysmal Subarachnoid Hemorrhage Patients: A Single-center Series.

Authors:  I-Sorn Phoominaonin; Somkiat Wongsuriyanan
Journal:  Asian J Neurosurg       Date:  2021-09-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.